The global Meningococcal Disease Treatment Market encompasses a range of vaccines, antibiotics, and monoclonal antibody therapies designed to prevent and treat infections caused by Neisseria meningitidis. Leading products include polysaccharide-protein conjugate vaccines, quadrivalent formulations covering serogroups A, C, W, and Y, and novel factor H binding protein (fHbp)–based vacc... https://www.patreon.com/posts/meningococcal-is-129589577?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link